Pub Date : 2026-01-27DOI: 10.1016/j.biochi.2026.01.010
R. Miranda-Blancas , M.C. Cardona-Echavarría , G. Saab-Rincón , C. Millán-Pacheco , A. Landa , E. Rudiño-Piñera
Laccases are oxidoreductase enzymes that require four electrons and four protons for each catalytic cycle to trigger the conversion of one oxygen molecule into two water molecules. However, for bacterial laccases, including the laccase from Thermus thermophilus HB27 (Tth-MCO), the complete proton transfer pathway from the solvent-exposed surface of the protein to the trinuclear center remains unclear. This paper describes new crystallographic structures of a partially copper-occupied Tth-MCO, subjected to a cumulative X-ray radiation strategy to uncover the effect of the X-ray driven chemical reduction on the residues related to the enzyme's proton relay. Additionally, we constructed and analyzed single and double mutants of residues H139 and E451 to assess their effect on the kinetic parameters of Tth-MCO. The proper folding of the mutants was evaluated using circular dichroism, while the structural stability of the mutants was analyzed using molecular dynamics calculations based on AlphaFold 2 models. Such analysis of the structural and kinetic data obtained provides deeper insights into the amino acids involved in the proton relay mechanism of Tth-MCO. Considering the conservation of amino acids involved in several bacterial laccase sequences, the proposed multi-step proton relay mechanism may also exist in other bacterial laccases.
{"title":"Assessing the role of E451, D452, and H139 in the catalytic function of a Thermus thermophilus bacterial laccase","authors":"R. Miranda-Blancas , M.C. Cardona-Echavarría , G. Saab-Rincón , C. Millán-Pacheco , A. Landa , E. Rudiño-Piñera","doi":"10.1016/j.biochi.2026.01.010","DOIUrl":"10.1016/j.biochi.2026.01.010","url":null,"abstract":"<div><div>Laccases are oxidoreductase enzymes that require four electrons and four protons for each catalytic cycle to trigger the conversion of one oxygen molecule into two water molecules. However, for bacterial laccases, including the laccase from <em>Thermus thermophilus</em> HB27 (<em>Tth</em>-MCO), the complete proton transfer pathway from the solvent-exposed surface of the protein to the trinuclear center remains unclear. This paper describes new crystallographic structures of a partially copper-occupied <em>Tth</em>-MCO, subjected to a cumulative X-ray radiation strategy to uncover the effect of the X-ray driven chemical reduction on the residues related to the enzyme's proton relay. Additionally, we constructed and analyzed single and double mutants of residues H139 and E451 to assess their effect on the kinetic parameters of <em>Tth</em>-MCO. The proper folding of the mutants was evaluated using circular dichroism, while the structural stability of the mutants was analyzed using molecular dynamics calculations based on AlphaFold 2 models. Such analysis of the structural and kinetic data obtained provides deeper insights into the amino acids involved in the proton relay mechanism of <em>Tth</em>-MCO. Considering the conservation of amino acids involved in several bacterial laccase sequences, the proposed multi-step proton relay mechanism may also exist in other bacterial laccases.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 70-79"},"PeriodicalIF":3.0,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146075136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.biochi.2026.01.009
Marina Ercilia Dasso, Cecilia Lucia Centola, Florencia Nerea Tabares, María Noel Galardo, Silvina Beatriz Meroni, María Fernanda Riera
Leptin is an adipokine with a role in male reproductive function. Sertoli cells (SCs) express leptin receptors, but leptin effects on SCs’ functions have been scarcely researched. SCs support germ cell development by providing various compounds, including transferrin and ketone bodies. Additionally, SC oxidize fatty acids (FAs) as their primary energy source and store them as triacylglycerols (TAGs) within lipid droplets (LDs), which serve as a crucial energy reserve within SCs. In the present study, we investigated whether leptin regulates the secretion and lipid storage in SCs and identified the potential signaling pathways involved. SC cultures were obtained from 20-day-old rats. The results show that leptin does not modify transferrin or 3-hydroxybutyrate secretion. However, it increases LD content and TAG levels in SCs. Leptin also augments the mRNA levels of FA transporter FAT/CD36, glycerol-3-phosphate-acyltransferase 3, and perilipin 1. We then explored the activation and the involvement of JAK/STAT3, PI3K/AKT, mTORC1/p70S6K, and PPARɣ-dependent pathways. Leptin treatment increases phosphorylated STAT3, AKT, and p70S6K levels. Also, leptin augments PPARɣ mRNA levels. In addition, we observed that Wortmannin (PI3K inhibitor), Rapamycin (mTORC1 inhibitor), and T0070907 (PPARɣ antagonist) decrease leptin-stimulated LD content, but Stattic (STAT3 inhibitor) has no effect. These results suggest that leptin regulates LD content through the activation of PI3K/AKT, mTORC1/p70S6K, and PPARɣ-dependent pathways. This study reveals that leptin increases lipid storage in SCs, a role that may help meet the seminiferous tubules' demand for FAs.
{"title":"Leptin increases lipid storage in Sertoli cells: Signaling pathways and cellular mechanisms involved","authors":"Marina Ercilia Dasso, Cecilia Lucia Centola, Florencia Nerea Tabares, María Noel Galardo, Silvina Beatriz Meroni, María Fernanda Riera","doi":"10.1016/j.biochi.2026.01.009","DOIUrl":"10.1016/j.biochi.2026.01.009","url":null,"abstract":"<div><div>Leptin is an adipokine with a role in male reproductive function. Sertoli cells (SCs) express leptin receptors, but leptin effects on SCs’ functions have been scarcely researched. SCs support germ cell development by providing various compounds, including transferrin and ketone bodies. Additionally, SC oxidize fatty acids (FAs) as their primary energy source and store them as triacylglycerols (TAGs) within lipid droplets (LDs), which serve as a crucial energy reserve within SCs. In the present study, we investigated whether leptin regulates the secretion and lipid storage in SCs and identified the potential signaling pathways involved. SC cultures were obtained from 20-day-old rats. The results show that leptin does not modify transferrin or 3-hydroxybutyrate secretion. However, it increases LD content and TAG levels in SCs. Leptin also augments the mRNA levels of FA transporter FAT/CD36, glycerol-3-phosphate-acyltransferase 3, and perilipin 1. We then explored the activation and the involvement of JAK/STAT3, PI3K/AKT, mTORC1/p70S6K, and PPARɣ-dependent pathways. Leptin treatment increases phosphorylated STAT3, AKT, and p70S6K levels. Also, leptin augments PPARɣ mRNA levels. In addition, we observed that Wortmannin (PI3K inhibitor), Rapamycin (mTORC1 inhibitor), and T0070907 (PPARɣ antagonist) decrease leptin-stimulated LD content, but Stattic (STAT3 inhibitor) has no effect. These results suggest that leptin regulates LD content through the activation of PI3K/AKT, mTORC1/p70S6K, and PPARɣ-dependent pathways. This study reveals that leptin increases lipid storage in SCs, a role that may help meet the seminiferous tubules' demand for FAs.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 59-69"},"PeriodicalIF":3.0,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-18DOI: 10.1016/j.biochi.2026.01.007
Hongwei Zhao, Chao Huang
Therapeutic resistance is a major obstacle in cancer treatment, often leading to recurrence and death. SUMOylation is a dynamic and reversible process of post-translational modification through a strict enzyme cascade that regulates the modification of target proteins by SUMO1-5 and SENP family proteins, which are involved in regulating protein stability, function, and localization to influence biological pathways, including cancers. SUMOylation contributes significantly to cancer drug resistance, undermining the efficacy of clinical treatment. Therefore, studying the role of SUMOylation in the development of cancer drug resistance has significant prospects. This review focuses on the important mechanistic role of SUMOylation in promoting or inhibiting cancer drug resistance and summarizes the feasibility of using SUMOylation as a therapeutic target for cancer treatment by combining SUMOylation inhibitors and anticancer drugs, which will provide new insights into overcoming cancer drug resistance and clinical cancer treatment.
{"title":"SUMOylation and anticancer drug resistance","authors":"Hongwei Zhao, Chao Huang","doi":"10.1016/j.biochi.2026.01.007","DOIUrl":"10.1016/j.biochi.2026.01.007","url":null,"abstract":"<div><div>Therapeutic resistance is a major obstacle in cancer treatment, often leading to recurrence and death. SUMOylation is a dynamic and reversible process of post-translational modification through a strict enzyme cascade that regulates the modification of target proteins by SUMO1-5 and SENP family proteins, which are involved in regulating protein stability, function, and localization to influence biological pathways, including cancers. SUMOylation contributes significantly to cancer drug resistance, undermining the efficacy of clinical treatment. Therefore, studying the role of SUMOylation in the development of cancer drug resistance has significant prospects. This review focuses on the important mechanistic role of SUMOylation in promoting or inhibiting cancer drug resistance and summarizes the feasibility of using SUMOylation as a therapeutic target for cancer treatment by combining SUMOylation inhibitors and anticancer drugs, which will provide new insights into overcoming cancer drug resistance and clinical cancer treatment.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 45-58"},"PeriodicalIF":3.0,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1016/j.biochi.2026.01.005
Alisa P. Chernyshova , Petr V. Sergiev , Dmitrii A. Lukianov , Vera A. Alferova
Antimicrobial resistance threatens the long-standing efficacy of antibiotics and underscores the need to expand, refine, and diversify antimicrobial therapies. Translation is a uniquely druggable process: its machinery is essential, conserved in bacteria, and sufficiently divergent from the eukaryotic counterpart to enable selectivity. This review synthesizes recent progress on inhibitors of initiation, elongation, termination, and recycling. High-resolution structural and biophysical studies have resolved longstanding ambiguities, reassigned ribosomal binding sites, uncovered stage-specific activities in scaffolds previously thought to act elsewhere, and revealed multistage, context-dependent mechanisms. Beyond the canonical stages, quality-control pathways that offer orthogonal points of intervention were observed. Collectively, these advances support structure-guided, context-aware, and hybrid/combination strategies for antibiotic design and therapeutic development.
{"title":"Recent advances in protein synthesis inhibitors","authors":"Alisa P. Chernyshova , Petr V. Sergiev , Dmitrii A. Lukianov , Vera A. Alferova","doi":"10.1016/j.biochi.2026.01.005","DOIUrl":"10.1016/j.biochi.2026.01.005","url":null,"abstract":"<div><div>Antimicrobial resistance threatens the long-standing efficacy of antibiotics and underscores the need to expand, refine, and diversify antimicrobial therapies. Translation is a uniquely druggable process: its machinery is essential, conserved in bacteria, and sufficiently divergent from the eukaryotic counterpart to enable selectivity. This review synthesizes recent progress on inhibitors of initiation, elongation, termination, and recycling. High-resolution structural and biophysical studies have resolved longstanding ambiguities, reassigned ribosomal binding sites, uncovered stage-specific activities in scaffolds previously thought to act elsewhere, and revealed multistage, context-dependent mechanisms. Beyond the canonical stages, quality-control pathways that offer orthogonal points of intervention were observed. Collectively, these advances support structure-guided, context-aware, and hybrid/combination strategies for antibiotic design and therapeutic development.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 21-44"},"PeriodicalIF":3.0,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1016/j.biochi.2026.01.004
Deepti Jamwal , Prince Kumar , Kunal Meena , Vikash Yadav , Rajesh Kumar , Nidhi Adlakha , Supratik Das
CELA3A and CELA3B are the primary elastases secreted by the human pancreas that are digestive enzymes and are markers for pancreatic exocrine insufficiency. CELA1, another family member, is not expressed in the human pancreas but has been detected in the mouse lung and human keratinocytes. However, the enzymatic activity and mechanism of function of human CELA1 has not been previously demonstrated. Here, we show using purified, recombinant pro-hCELA1, that it is activated by trypsin and has pancreatic elastase-like activity. We show that pro-hCELA1 cleavage by trypsin is blocked by aprotinin. We have determined the enzyme kinetics of the active fraction of recombinant hCELA1 and show that it follows steady-state kinetics with a higher substrate affinity than commercial porcine pancreatic elastase.
{"title":"Human CELA1 has pancreatic elastase-like activity","authors":"Deepti Jamwal , Prince Kumar , Kunal Meena , Vikash Yadav , Rajesh Kumar , Nidhi Adlakha , Supratik Das","doi":"10.1016/j.biochi.2026.01.004","DOIUrl":"10.1016/j.biochi.2026.01.004","url":null,"abstract":"<div><div>CELA3A and CELA3B are the primary elastases secreted by the human pancreas that are digestive enzymes and are markers for pancreatic exocrine insufficiency. CELA1, another family member, is not expressed in the human pancreas but has been detected in the mouse lung and human keratinocytes. However, the enzymatic activity and mechanism of function of human CELA1 has not been previously demonstrated. Here, we show using purified, recombinant pro-hCELA1, that it is activated by trypsin and has pancreatic elastase-like activity. We show that pro-hCELA1 cleavage by trypsin is blocked by aprotinin. We have determined the enzyme kinetics of the active fraction of recombinant hCELA1 and show that it follows steady-state kinetics with a higher substrate affinity than commercial porcine pancreatic elastase.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 18-20"},"PeriodicalIF":3.0,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145954288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.biochi.2026.01.001
Francesca Giordano , Diogo H.P. Silva , Elena Forte , Alessandro Giuffrè , João B. Vicente
Hydrogen sulfide (H2S) regulates multiple human physiological processes, its reactivity and range of action being tightly controlled through regulation of H2S-synthesizing and -detoxifying enzymes. H2S detoxification is mainly achieved by a mitochondrial sulfide detoxifying pathway including persulfide dioxygenase (PDO). Human PDO (known as ethylmalonic encephalopathy protein 1, ETHE1), a homodimeric enzyme with a mononuclear iron centre active site, catalyzes the conversion of glutathione persulfide (GSSH) and O2 to reduced glutathione (GSH) and sulfite. Here we report that ETHE1 is potently inhibited by authentic nitric oxide (NO) gas at physiological concentrations, as observed by high resolution respirometry. Inhibition is reversible, occurs via NO binding to the reduced mononuclear iron center and becomes more potent and persistent at lower O2 levels. Incubation with s-nitrosoglutathione (GSNO) also appears to partially and transiently inhibit ETHE1, this effect likely resulting from s-nitrosation of cysteine residues. While ETHE1 is devoid of NO reductase activity, in aerobic conditions it displays low NO degrading activity. These findings unravel a novel layer of cross-regulation between the H2S and NO gasotransmitters with possible implications on the regulation of numerous physiological and pathophysiological processes.
{"title":"Human mitochondrial persulfide dioxygenase is potently and reversibly inhibited by nitric oxide","authors":"Francesca Giordano , Diogo H.P. Silva , Elena Forte , Alessandro Giuffrè , João B. Vicente","doi":"10.1016/j.biochi.2026.01.001","DOIUrl":"10.1016/j.biochi.2026.01.001","url":null,"abstract":"<div><div>Hydrogen sulfide (H<sub>2</sub>S) regulates multiple human physiological processes, its reactivity and range of action being tightly controlled through regulation of H<sub>2</sub>S-synthesizing and -detoxifying enzymes. H<sub>2</sub>S detoxification is mainly achieved by a mitochondrial sulfide detoxifying pathway including persulfide dioxygenase (PDO). Human PDO (known as ethylmalonic encephalopathy protein 1, ETHE1), a homodimeric enzyme with a mononuclear iron centre active site, catalyzes the conversion of glutathione persulfide (GSSH) and O<sub>2</sub> to reduced glutathione (GSH) and sulfite. Here we report that ETHE1 is potently inhibited by authentic nitric oxide (NO) gas at physiological concentrations, as observed by high resolution respirometry. Inhibition is reversible, occurs via NO binding to the reduced mononuclear iron center and becomes more potent and persistent at lower O<sub>2</sub> levels. Incubation with <span><em>s</em></span>-nitrosoglutathione (GSNO) also appears to partially and transiently inhibit ETHE1, this effect likely resulting from <span><em>s</em></span>-nitrosation of cysteine residues. While ETHE1 is devoid of NO reductase activity, in aerobic conditions it displays low NO degrading activity. These findings unravel a novel layer of cross-regulation between the H<sub>2</sub>S and NO gasotransmitters with possible implications on the regulation of numerous physiological and pathophysiological processes.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"242 ","pages":"Pages 143-148"},"PeriodicalIF":3.0,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.biochi.2026.01.003
Kalina Wegrzyn, Tomasz Wilanowski
Phase separation underlies the formation of subcellular structures known as biomolecular condensates or membraneless organelles. In the last 15 years, a great effort has been made to characterize the biophysical properties of condensates and their role in cellular processes, including the regulation of gene expression. In this article, we provide an overview of mechanisms of phase separation in the cellular milieu, including the role of intrinsically disordered proteins, and present a repertoire of methods used to study condensate properties. Additionally, we describe recent advances regarding the role of phase separation in regulation of gene expression.
{"title":"Phase separation in regulation of gene expression: current methodological and conceptual approaches","authors":"Kalina Wegrzyn, Tomasz Wilanowski","doi":"10.1016/j.biochi.2026.01.003","DOIUrl":"10.1016/j.biochi.2026.01.003","url":null,"abstract":"<div><div>Phase separation underlies the formation of subcellular structures known as biomolecular condensates or membraneless organelles. In the last 15 years, a great effort has been made to characterize the biophysical properties of condensates and their role in cellular processes, including the regulation of gene expression. In this article, we provide an overview of mechanisms of phase separation in the cellular milieu, including the role of intrinsically disordered proteins, and present a repertoire of methods used to study condensate properties. Additionally, we describe recent advances regarding the role of phase separation in regulation of gene expression.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"243 ","pages":"Pages 1-17"},"PeriodicalIF":3.0,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.biochi.2026.01.002
Kamil Aleksander Sobieszek , Jakub Frankowski , Mateusz Labudda
Nutritional management in cancer patients with an ileostomy poses specific challenges due to impaired nutrient absorption, elevated metabolic demands, and the need to control serum urate levels. This review examines the biochemical and clinical relevance of plant-based foods in addressing these issues, with particular emphasis on purine content, digestibility, and metabolic outcomes. Current evidence shows that legumes, soy products, nuts, seeds, whole grains, vegetables, fruits, and fortified foods generally contain low to moderate purine levels and are well tolerated by ileostomy patients. Incorporating these foods into individualized dietary plans supports adequate protein and micronutrient intake, enhances tissue repair, and reduces the risk of gout flares without compromising gastrointestinal function. Moreover, plant-derived bioactive compounds and antioxidants may mitigate inflammation and oxidative stress associated with cancer progression and hyperuricemia. Collectively, a carefully designed plant-based diet can meet the nutritional needs of cancer patients with an ileostomy while contributing to effective gout management and improved metabolic homeostasis.
{"title":"Dietary modulation of purine metabolism and uric acid homeostasis in cancer patients with an ileostomy","authors":"Kamil Aleksander Sobieszek , Jakub Frankowski , Mateusz Labudda","doi":"10.1016/j.biochi.2026.01.002","DOIUrl":"10.1016/j.biochi.2026.01.002","url":null,"abstract":"<div><div>Nutritional management in cancer patients with an ileostomy poses specific challenges due to impaired nutrient absorption, elevated metabolic demands, and the need to control serum urate levels. This review examines the biochemical and clinical relevance of plant-based foods in addressing these issues, with particular emphasis on purine content, digestibility, and metabolic outcomes. Current evidence shows that legumes, soy products, nuts, seeds, whole grains, vegetables, fruits, and fortified foods generally contain low to moderate purine levels and are well tolerated by ileostomy patients. Incorporating these foods into individualized dietary plans supports adequate protein and micronutrient intake, enhances tissue repair, and reduces the risk of gout flares without compromising gastrointestinal function. Moreover, plant-derived bioactive compounds and antioxidants may mitigate inflammation and oxidative stress associated with cancer progression and hyperuricemia. Collectively, a carefully designed plant-based diet can meet the nutritional needs of cancer patients with an ileostomy while contributing to effective gout management and improved metabolic homeostasis.</div></div>","PeriodicalId":251,"journal":{"name":"Biochimie","volume":"242 ","pages":"Pages 134-142"},"PeriodicalIF":3.0,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}